Shandong Wohua Pharmaceutical Co., Ltd. (SZSE: 002107)
Health Care · Pharmaceuticals · CN
CN¥6.25
-2.50% today · -10.8% 1Y
Shandong Wohua Pharmaceutical Co., Ltd. (SZSE: 002107) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $536.65M and employs 1,018 people.
Over the last twelve months the share price has lost 10.8%, trading between 5.47 and 8.47.
Tweenvest scores Shandong Wohua Pharmaceutical Co., Ltd. across four factors: quality 75/100, value 38/100, growth 15/100, dividend 55/100. Its strongest factor is quality.
002107 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $536.65M
- Revenue (TTM)
- $115.56M
- P/E
- 29.79
- EPS
- 0.21
- Dividend yield
- 3.74%
- Beta (5Y)
- 0.31
- 52-week high
- CN¥8.47
- 52-week low
- CN¥5.47
- Avg volume (3M)
- —
- Shares outstanding
- 577.21M
- Employees
- 1,018
- Next earnings
- —
About Shandong Wohua Pharmaceutical Co., Ltd.
Shandong Wohua Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the development, production, and distribution of a broad array of medicinal products across the country. The company's extensive product portfolio addresses various therapeutic categories. Key offerings include Xinkeshu tablets, Naoxueshu oral solutions, and Tongluo Huayu capsules, which are specifically formulated for cardiovascular and cerebrovascular health. Beyond these, Shandong Wohua also supplies medications for respiratory conditions, drugs targeting the urinary and digestive systems, anti-rheumatic treatments, and sedative agents. Furthermore, it provides specialized pharmaceuticals tailored for women and children. Headquartered in Weifang, China, the company operates as a subsidiary under the ownership of Beijing Zhongzheng Wanrong Investment (Group) Co., Ltd.
- ISIN
- CNE000001QB8
- Founded
- 2003
- Listed since
- Jan 24, 2007
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,240.63 | -1.18% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.52 | +0.47% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.55 | -1.31% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.93 | -0.50% |
Figures last refreshed Aug 18, 2026.